Peroxisome Proliferator-activated Receptor Gamma: Genetic Polymorphisms Are Not Associated With Metabolic Syndrome in Taiwan

Fu-Hsiung Su, Mei-Chieh Chen, Chiu Shong Liu, Yi Chieh Huang, Cheng Chieh Lin, Fung Chang Sung, Chien-Tien Su, Chih-Ching Yeh

Research output: Contribution to journalArticle

Abstract

Background: Peroxisome proliferator-activated receptor gamma (PPARγ) is one of the transcriptional regulators of adipocyte differentiation; it was suggested to be a candidate gene modulating obesity, insulin resistance, and dyslipidemia. Aim: This study explored the association between PPARγ genetic polymorphisms (Pro12Ala and C161T) and the risk of metabolic syndrome (MetS) in Han Taiwanese participants. Methods: This cross-sectional study included 346 participants with MetS and 804 without MetS. The parameters for fasting serum concentrations of glucose and lipids were measured. The presence or absence of MetS was determined according to the modified criteria of the third report of the National Cholesterol Education Program's Adult Treatment Panel (NCEP ATP III). PPARγ genetic polymorphisms were genotyped with real-time polymerase chain reaction. Results: Frequencies of the Pro12Ala Ala allele and C161T T allele among non-MetS participants were 5.2% and 26.0%, respectively. The Pro12Ala and C161T polymorphisms were not significantly associated with MetS risk (odds ratio=0.75, 95% confidence interval=0.47-1.21 and odds ratio=0.92, 95% confidence interval=0.70-1.20). No significant association was observed between haplotypes of the PPARγ gene and MetS risk even following stratification by sex. Conclusion: This result suggests that PPARγ C161T and Pro12Ala genetic polymorphisms may not be associated with MetS among Han Taiwanese.

Original languageEnglish
Pages (from-to)195-199
Number of pages5
JournalJournal of Experimental and Clinical Medicine(Taiwan)
Volume6
Issue number6
DOIs
Publication statusPublished - Dec 1 2014

Fingerprint

PPAR gamma
Genetic Polymorphisms
Taiwan
Odds Ratio
Alleles
Confidence Intervals
Dyslipidemias
Adipocytes
Haplotypes
Genes
Insulin Resistance
Real-Time Polymerase Chain Reaction
Fasting
Obesity
Cross-Sectional Studies
Adenosine Triphosphate
Cholesterol
Lipids
Education
Glucose

Keywords

  • Genetic polymorphism
  • Metabolic syndrome
  • Peroxisome proliferator-activated receptor gamma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Peroxisome Proliferator-activated Receptor Gamma : Genetic Polymorphisms Are Not Associated With Metabolic Syndrome in Taiwan. / Su, Fu-Hsiung; Chen, Mei-Chieh; Liu, Chiu Shong; Huang, Yi Chieh; Lin, Cheng Chieh; Sung, Fung Chang; Su, Chien-Tien; Yeh, Chih-Ching.

In: Journal of Experimental and Clinical Medicine(Taiwan), Vol. 6, No. 6, 01.12.2014, p. 195-199.

Research output: Contribution to journalArticle

@article{5827a384f25447f68b1cdeab00089e3d,
title = "Peroxisome Proliferator-activated Receptor Gamma: Genetic Polymorphisms Are Not Associated With Metabolic Syndrome in Taiwan",
abstract = "Background: Peroxisome proliferator-activated receptor gamma (PPARγ) is one of the transcriptional regulators of adipocyte differentiation; it was suggested to be a candidate gene modulating obesity, insulin resistance, and dyslipidemia. Aim: This study explored the association between PPARγ genetic polymorphisms (Pro12Ala and C161T) and the risk of metabolic syndrome (MetS) in Han Taiwanese participants. Methods: This cross-sectional study included 346 participants with MetS and 804 without MetS. The parameters for fasting serum concentrations of glucose and lipids were measured. The presence or absence of MetS was determined according to the modified criteria of the third report of the National Cholesterol Education Program's Adult Treatment Panel (NCEP ATP III). PPARγ genetic polymorphisms were genotyped with real-time polymerase chain reaction. Results: Frequencies of the Pro12Ala Ala allele and C161T T allele among non-MetS participants were 5.2{\%} and 26.0{\%}, respectively. The Pro12Ala and C161T polymorphisms were not significantly associated with MetS risk (odds ratio=0.75, 95{\%} confidence interval=0.47-1.21 and odds ratio=0.92, 95{\%} confidence interval=0.70-1.20). No significant association was observed between haplotypes of the PPARγ gene and MetS risk even following stratification by sex. Conclusion: This result suggests that PPARγ C161T and Pro12Ala genetic polymorphisms may not be associated with MetS among Han Taiwanese.",
keywords = "Genetic polymorphism, Metabolic syndrome, Peroxisome proliferator-activated receptor gamma, Genetic polymorphism, Metabolic syndrome, Peroxisome proliferator-activated receptor gamma",
author = "Fu-Hsiung Su and Mei-Chieh Chen and Liu, {Chiu Shong} and Huang, {Yi Chieh} and Lin, {Cheng Chieh} and Sung, {Fung Chang} and Chien-Tien Su and Chih-Ching Yeh",
year = "2014",
month = "12",
day = "1",
doi = "10.1016/j.jecm.2014.10.013",
language = "English",
volume = "6",
pages = "195--199",
journal = "Journal of Experimental and Clinical Medicine",
issn = "1878-3317",
publisher = "Elsevier Taiwan LLC",
number = "6",

}

TY - JOUR

T1 - Peroxisome Proliferator-activated Receptor Gamma

T2 - Genetic Polymorphisms Are Not Associated With Metabolic Syndrome in Taiwan

AU - Su, Fu-Hsiung

AU - Chen, Mei-Chieh

AU - Liu, Chiu Shong

AU - Huang, Yi Chieh

AU - Lin, Cheng Chieh

AU - Sung, Fung Chang

AU - Su, Chien-Tien

AU - Yeh, Chih-Ching

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Background: Peroxisome proliferator-activated receptor gamma (PPARγ) is one of the transcriptional regulators of adipocyte differentiation; it was suggested to be a candidate gene modulating obesity, insulin resistance, and dyslipidemia. Aim: This study explored the association between PPARγ genetic polymorphisms (Pro12Ala and C161T) and the risk of metabolic syndrome (MetS) in Han Taiwanese participants. Methods: This cross-sectional study included 346 participants with MetS and 804 without MetS. The parameters for fasting serum concentrations of glucose and lipids were measured. The presence or absence of MetS was determined according to the modified criteria of the third report of the National Cholesterol Education Program's Adult Treatment Panel (NCEP ATP III). PPARγ genetic polymorphisms were genotyped with real-time polymerase chain reaction. Results: Frequencies of the Pro12Ala Ala allele and C161T T allele among non-MetS participants were 5.2% and 26.0%, respectively. The Pro12Ala and C161T polymorphisms were not significantly associated with MetS risk (odds ratio=0.75, 95% confidence interval=0.47-1.21 and odds ratio=0.92, 95% confidence interval=0.70-1.20). No significant association was observed between haplotypes of the PPARγ gene and MetS risk even following stratification by sex. Conclusion: This result suggests that PPARγ C161T and Pro12Ala genetic polymorphisms may not be associated with MetS among Han Taiwanese.

AB - Background: Peroxisome proliferator-activated receptor gamma (PPARγ) is one of the transcriptional regulators of adipocyte differentiation; it was suggested to be a candidate gene modulating obesity, insulin resistance, and dyslipidemia. Aim: This study explored the association between PPARγ genetic polymorphisms (Pro12Ala and C161T) and the risk of metabolic syndrome (MetS) in Han Taiwanese participants. Methods: This cross-sectional study included 346 participants with MetS and 804 without MetS. The parameters for fasting serum concentrations of glucose and lipids were measured. The presence or absence of MetS was determined according to the modified criteria of the third report of the National Cholesterol Education Program's Adult Treatment Panel (NCEP ATP III). PPARγ genetic polymorphisms were genotyped with real-time polymerase chain reaction. Results: Frequencies of the Pro12Ala Ala allele and C161T T allele among non-MetS participants were 5.2% and 26.0%, respectively. The Pro12Ala and C161T polymorphisms were not significantly associated with MetS risk (odds ratio=0.75, 95% confidence interval=0.47-1.21 and odds ratio=0.92, 95% confidence interval=0.70-1.20). No significant association was observed between haplotypes of the PPARγ gene and MetS risk even following stratification by sex. Conclusion: This result suggests that PPARγ C161T and Pro12Ala genetic polymorphisms may not be associated with MetS among Han Taiwanese.

KW - Genetic polymorphism

KW - Metabolic syndrome

KW - Peroxisome proliferator-activated receptor gamma

KW - Genetic polymorphism

KW - Metabolic syndrome

KW - Peroxisome proliferator-activated receptor gamma

UR - http://www.scopus.com/inward/record.url?scp=84916236262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916236262&partnerID=8YFLogxK

U2 - 10.1016/j.jecm.2014.10.013

DO - 10.1016/j.jecm.2014.10.013

M3 - Article

AN - SCOPUS:84916236262

VL - 6

SP - 195

EP - 199

JO - Journal of Experimental and Clinical Medicine

JF - Journal of Experimental and Clinical Medicine

SN - 1878-3317

IS - 6

ER -